mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.4 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |